Needham analyst Mike Matson raised the firm’s price target on Stryker (SYK) to $454 from $448 and keeps a Buy rating on the shares. The firm cites the company’s Q4 revenue and EPS beat while noting that Stryker again saw broad-based strength across most of its businesses, driven by strong procedure volumes, new products, and its capital equipment backlog, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Stryker price target lowered to $437 from $450 at Baird
- Stryker price target raised to $412 from $410 at BTIG
- Stryker: Sustained Double-Digit Growth and Operating Leverage Support Buy Rating Despite 2026 Tariff Headwinds
- Closing Bell Movers: Apple reverse post-earnings gains; Sandisk rallies
- Stryker sees FY26 adjusted EPS $14.90-$15.10, consensus $14.94